Development of a peptide-based compound that inhibits osteoclastogenesis by targeting TRAF6 to modulate its downstream signaling.

Masataka Anzai

[1P-375(1T07a-11)] Development of a peptide-based compound that inhibits osteoclastogenesis by targeting TRAF6 to modulate its downstream signaling.

^〇Masataka Anzai¹, Miho Takahashi¹, Keizo Nishikawa², Hiroaki Sakurai³, Jun-ichiro Inoue⁴, Kiyotaka Nishikawa¹ (1.Lab. of Mol. Life Sci., Facult. of Life and Med. Sci., Doshisha Univ., 2.Lab. of Cell Biol. and Metab. Biochem., Facult. of Life and Med. Sci., Doshisha Univ., 3.Dep. of Cancer Cell Biol., Facul. of Pharma. Sci., Univ. of Toyama, 4.Res. Platform Office, The Inst. of Med. Sci., The Univ. of Tokyo)

キーテクノロジー：多価型ペプチドライブラリー法

TRAF6、破骨細胞分化、RANK、多価型ペプチド、p38

manzai@mail.doshisha.ac.jp

Contents of this site has moved to the member page of The Japanese Biochemical Society: https://member.jbsoc.or.jp/mypage/
You can access the abstracts without credentials by accessing them via the member page.

You need the membership number and password to access the member page. Please contact the journal office for any inquiries.

Journal Office Contact Information:
E-mail:jbs-ho@jbsoc.or.jp
Tel:03(3815)1913 Fax:03(3815)1934

The 96th Annual Meeting of the Japanese Biochemical Society

[1P-375(1T07a-11)] Development of a peptide-based compound that inhibits osteoclastogenesis by targeting TRAF6 to modulate its downstream signaling.

Password